Patents Assigned to ORTHOCELL LIMITED
-
Patent number: 12653536Abstract: The subject invention relates generally to the repair of severed or damaged nerve and/or epineurium in a patient in need of such treatment. In particular, the present invention provides devices and methods of repairing severed or damaged nerve and/or epincurium. In some embodiments, a device is provided for the in vivo repair of severed or damaged nerve and/or epineurium comprising: a pliable collagen membrane comprising a first surface and a second surface, said first surface having a plurality of protruding collagen bundles and said second surface comprising a plurality of apertures, said apertures and said collagen bundles arranged to form a self-engaging attachment when said first surface and said second surface are placed together.Type: GrantFiled: April 27, 2022Date of Patent: June 16, 2026Assignee: Orthocell LimitedInventors: Minghao Zheng, Paul Anderson
-
Patent number: 12329366Abstract: The present disclosure provides a medical procedure kit for ameliorating tissue damage in a patient, the kit comprising a container enclosing a receptacle, an extractor for extracting biological material including autologous cells from the patient, a strainer for straining autologous cells from the biological material and an implantable support having a surface onto which the autologous cells can adhere, the implantable support configured to be received by the receptacle. Also disclosed are related methods of manufacturing a medical material and using the medical procedure kit.Type: GrantFiled: June 5, 2018Date of Patent: June 17, 2025Assignee: Orthocell LimitedInventors: Paul Anderson, Ming Hao Zheng
-
Publication number: 20230174943Abstract: The invention pertains to the technical field of a method for isolating and expanding tendon cells in vitro. The invention also relates to cellular compositions comprising such tendon cells and use thereof to repair tendon tissue. In particular, the present invention relates to a cellular composition comprising isolated tendon cells which cells express tenomodulin (TNMD) and scleraxis (Scx).Type: ApplicationFiled: December 6, 2021Publication date: June 8, 2023Applicant: Orthocell LimitedInventors: Ming-Hao Zheng, Monique Cannon
-
Patent number: 11517419Abstract: There is disclosed a collagen construct comprising a plurality of elongate strips, wherein each strip contains a plurality of collagen fibres that are substantially aligned along the length of the respective strips, and the strips are braided or woven together to produce a collagen construct in the form of a rope that can be used for replacing tendons or ligaments, such as cruciate ligaments. Also disclosed is a method for making or producing the collagen construct from a collagen membrane having a plurality of collagen fibres being substantially aligned parallel to each other in a common direction. The membrane is cut along cut lines that are orientated substantially parallel to that common direction, thereby to separate elongate strips from the membrane. The strips are then braided or woven together to form the collagen construct.Type: GrantFiled: December 6, 2019Date of Patent: December 6, 2022Assignee: Orthocell LimitedInventor: Ming Hao Zheng
-
Patent number: 10524895Abstract: There is disclosed a collagen construct comprising a plurality of elongate strips, wherein each strip contains a plurality of collagen fibres that are substantially aligned along the length of the respective strips, and the strips are braided or woven together to produce a collagen construct in the form of a rope that can be used for replacing tendons or ligaments, such as cruciate ligaments. Also disclosed is a method for making or producing the collagen construct from a collagen membrane having a plurality of collagen fibres being substantially aligned parallel to each other in a common direction. The membrane is cut along cut lines that are orientated substantially parallel to that common direction, thereby to separate elongate strips from the membrane. The strips are then braided or woven together to form the collagen construct.Type: GrantFiled: October 12, 2015Date of Patent: January 7, 2020Assignee: Orthocell LimitedInventor: Ming Hao Zheng
-
Patent number: 9889233Abstract: A medical composition is disclosed, which is injectable and which comprises a mixture of native components, which are obtainable by culturing one or more cell samples from a human or animal during normal conditions, said native components being included in the group consisting of growth factors, extracellular matrix proteins, and other substances produced by said cell samples during normal conditions, and a pharmaceutically acceptable carrier, as well as a method for producing the native components, a method for producing the medical composition, a method for treating a subject in need of tissue repair by injection of the medical composition, and use of said mixture of native components for the production of said medical composition for tissue repair via injection.Type: GrantFiled: November 12, 2015Date of Patent: February 13, 2018Assignee: ORTHOCELL LIMITEDInventor: Lars Lidgren
-
Publication number: 20170224344Abstract: The present invention relates to a sutureless method of repairing soft tissue defects in soft tissue including ligaments such as anterior cruciate ligaments (ACLs). In particular, the present invention relates a sutureless method of repairing soft tissue defect comprising: (i) providing a collagen-containing patch adapted to enclose at least a portion of said soft tissue defect; (ii) contacting said soft tissue defect and/or collagen-containing patch with a sensitizer; (Hi) enclosing said soft tissue defect in said collagen-containing patch to produce a bioactive chamber; and (iv) adhering said collagen-containing patch to said soft tissue defect without sutures.Type: ApplicationFiled: October 12, 2015Publication date: August 10, 2017Applicant: ORTHOCELL LIMITEDInventor: Ming Hao Zheng